Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
169
mentions
- X 140
- News 22
- Blogs 3
- YouTube 2
- +1 more
Yi-Long Wu
PubHawk tracks social media discussions for 2 articles by authors named Yi-Long Wu.
Mentions
286
Peak: 108 in Feb 2022
across 2 tracked articles
Extended reach
1,414,223
potential audience
Total likes
502
Video views
132
Mentions per month
Sep 2012 – Jul 2025Where it's discussed
-
X / Twitter235 posts
-
News40 articles
-
Facebook4 posts
-
Blogs4 articles
-
YouTube3 videos
Tracked by PubHawk
Most discussed articles
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy.
117
mentions
- X 95
- News 18
- Facebook 2
- YouTube 1
- +1 more
From PubMed
All publications
Searching PubMed…